Helena is CEO of Bioalvo and will participate at BioMarine in the women debate
Helena
Vieira is the CEO and co-founder of BIOALVO SA, a natural products
biotech company focusing on maximizing bioactive ingredient discovery
using its own proprietary technology and libraries, since 2005. She
holds a post graduation in Leadership & Strategy in Pharma &
Bioptech, from Harvard Business School, Boston, USA and a PhD in
Biomedicine from Imperial College of London, UK.
She was also a researcher in the molecular and cellular biology fields,
in Portugal and UK, and completed several other post
graduations in the human molecular genetics field. Before starting-up
BIOALVO, she was an Associated Professor and Scientific Coordinator of
the biomedical and clinical engineering degrees at the Engineering
Faculty of Catholic University of Portugal, Lisbon. She also
has experience as Principle Investigator at the Biomedical Nucleus,
since 2005, at the same university. Currently, Helena is responsible for
the supervision & teaching of Entrepreneurship, Innovation and
Technology Transfer course to Master Students in the Faculty of
Sciences, University of Lisbon. She is currently leading a team of 15
people while managing one of the TOP 3 biotech companies in Portugal.
Helena is highly skilled in biotech strategy and
major technical aspects of natural products bioactive
discovery and development fro several industries, from pharmaceutical to
cosmetics and nutraceutics.
About BIOALVO
BIOALVO,
the Biotech for Natural Products, is a Portuguese start-up company with
a privileged access to the biggest continental platform in Europa –
Portugal’s. BIOALVO develops fully integrated biotech solutions to
maximize natural products market applications in areas as diverse as
cosmetics, household products, nutraceuticals, pharmaceuticals or even
industrial. BIOALVO holds unique and proprietary microorganisms natural
extracts collections form the unique Portuguese deep Ocean (PharmaBUG,
LUSOMAREXTRACT) and Land (LUSOEXTRACT) ecosystems and couples these
assets with its unique and patented discovery technology GPS D2, its
extensive assay development and HTS robotics capacity as well as
production and full development capacities in house, providing its
partners with a one-stop-shop solution for their innovation in natural
product development. By using BIOALVO’s organization as a fully
integrated or modular partner in the different stages of a novel
ingredient development our partners are bringing a natural product
solution closer and quicker to market. In the last year BIOALVO has
identified and is developing novel and innovative ingredients such as a
new marine botox-like ingredients with topical action for pharmaceutical
and cosmetical applications, novel marine natural anti-UV protectors
for cosmetic and textile applications and novel marine neuroprotective
and anti-inflammatories compounds with tremendous potential for several
other applications. Mostly, at BIOALVO we thrive to find sustainable and
natural solutions in the Portuguese ocean and ecosystems to solve
current society problems, making everyone’s life healthier, better and
more natural. In 2011 BIOALVO was awarded the highest national prize for
biodiversity and sustainability (BES BIODIVERSIDADE 2011) and was
ranked at the TOP 6 best companies in Europe’s Most Innovative Biotech
SME Award 2011
Come and visit us in BIOMARINE CONVENTION 2012 in London and find out
our latest developments and contributions to a better world!
No comments:
Post a Comment